Iowa's Department of Health and Human Services, which manages the two health insurers that delivered care to adults and children in the state’s Medicaid program last year, was alleged to provide inadequate mental and behavioral health care to children on Medicaid.
Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.
Panelists discuss how pharmacists should implement follow-up practices for patients who need additional pneumococcal vaccine doses, including scheduling appointments while patients are present, using text or phone reminders, queuing future vaccine prescriptions in computer systems to align with due dates, utilizing state immunization registries for tracking and alerts when available, and providing patients with vaccination records in their preferred format while ensuring compliance with state information-sharing requirements to guarantee complete protection through proper series completion.
Evidence of the relationship between probiotics and antibiotics is lacking.
Mitchell Barnett, PharmD, MS, discusses what lessons can be learned from a community pharmacy drug disposal program.
Opioid use disorder during pregnancy is stigmatized, but these patients deserve compassionate, nonjudgmental care.
During Viral Hepatitis Awareness Month, Jeff Goad, PharmD, MPH, joined Over the Counter to discuss hepatitis vaccines and the common trends pharmacists in this space should keep in mind.
Investing strategically in your pharmacy’s front end can enhance the customer experience and build lasting relationships
Unfortunately, even though the need for making proper dose adjustments for kidney function is well-recognized, clinicians face many challenges in doing so.
On June 26, 2024, the FDA approved ensifentrine (Ohtuvayre) for the treatment of COPD.
The Summit provides a rare opportunity for professionals to dive deep into emerging healthcare technologies and treatment models.
Vaccination greatly reduces the probability of experiencing severe COVID-19 in both variants. Adults between the ages of 40 to 59 years saw the most significant reduction in risk when compared to individuals in other age categories.
Researchers of a new paper discuss the inconsistencies between gene and cell therapy indications and payor coverage.
Part of the risk of developing kidney involvement begins when type 1 diabetes mellitus (T1DM) sets in and establishes itself in the patient, with up to 65% of children experiencing acute kidney injury during T1DM onset, which can further predispose to the development of future chronic kidney disease.
Patients with advanced or recurrent endometrial cancer treated with Keytruda plus chemotherapy had improved progression-free survival compared with chemotherapy alone.
Does anxiety justify an exemption from vaccine mandates among health care workers?
Women with PCOS were more likely to begin fertility treatment with ovulation induction compared to those without PCOS.
Do no harm, even though your patient might.
Seven major clinical trials reveal semaglutide’s expanding benefits beyond glucose control, showing promise in kidney, heart, liver, vascular, and obesity-related outcomes.
This past year has seen several important new drug approvals and labeling updates for children. Here is what you should know.
A 1-year observational follow-up of a 3-month randomized controlled trial provides insight into the benefits of advanced hybrid closed-loop system use in people with type 1 diabetes using multiple daily injections and self-monitoring of blood glucose.
Despite telehealth’s rise in popularity during the height of COVID-19, many individuals still aren't aware that it's a viable option.
Pharmacogenetics can inform precision prescribing practices, which in turn can solve the inefficiencies of current prescribing models.
A conversation with Antonia Biggs, PhD, professor and acting director of the Advancing New Standards in Reproductive Health Program at the University of California, San Francisco.
In a world where drug shortages are one of the most pressing issues for pharmacy businesses, there are certain tools making a significant difference in helping patients access their drugs at the pharmacy.
Last August, zuranolone (Zurzuvae) became the first FDA-approved pill to treat postpartum depression in adults.
Spikevax is now the second COVID-19 vaccine approved by regulators.
Attorneys from The Phoenix Law Group joined Drug Topics at NCPDP 2025 to discuss the current state of pharmacy benefit manager reform and where it may end up in the near future.
Stimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.
Kelly Goode, PharmD, BCPS, FAPhA, FCCP, professor in the department of pharmacotherapy and outcomes science at Virginia Commonwealth University, discusses the current landscape of immunization recommendations.